In addition, Mecp2+/--HFD mice showed more severe subcutaneous and visceral fat composition, fatty liver, glucose intolerance, insulin resistance, and leptin resistance than WT-HFD mice. The gene discussed is MECP2; the disease is Insulin resistance.